Almogran 12.5mg film-coated tablets
1. What Almogran is and what it is used for
2. What you need to know before you take Almogran
3. How to take Almogran
4. Possible side effects
5. How to store Almogran
6. Contents of the pack and other information
Almogran is an antimigraine agent which belongs to a class of compounds known as selective serotonin receptor agonists. Almogran is believed to reduce the inflammatory response associated with migraines by binding to the serotonin receptors in the brain (cranial) blood vessels and causing them to narrow.
Almogran is used to relieve headaches associated with migraine attacks with or without aura.
Talk to your doctor, pharmacist or nurse before taking Almogran
It has been suggested that excessive use of an anti-migraine medicinal product can lead to daily chronic headache.
Children under the age of 18 should not take Almogran.
If you are over 65 years of age you should speak to your doctor before using this medicinal product.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Please tell your doctor:
Almotriptan should not be taken at the same time as ergotamine-containing medicines, which are also used to treat migraine. However, the medicines may be taken after one another: provided a suitable amount of time is left between taking each medicine
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Only very limited data is available for almotriptan in pregnant patients. Almogran should only be used during pregnancy if instructed by your doctor and only after they have carefully considered the benefits and risks.
Caution should be taken when using this medicine whilst breast-feeding. You should avoid breast-feeding for 24 hours after taking this medicine.
Almogran may cause drowsiness. If you are affected, you should not drive or use any tools or machines.
Almogran should only be used to treat an actual migraine attack and not to prevent migraine attacks or headaches.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one 12.5 mg tablet which should be taken as early as possible after the onset of the migraine attack. If your migraine attack does not subside, do not take more than one tablet for the same attack.
If you experience a second migraine attack within 24 hours, a second 12.5 mg tablet can be taken but you must leave at least two hours between your first and second tablet.
The maximum daily dose is two (12.5 mg) tablets within 24 hours.
Tablet(s) should be swallowed with liquid (e.g. water) and can be taken with or without food.
You should take Almogran as soon as possible after the onset of the migraine, although it is still effective if taken at a later stage.
If you have severe kidney disease do not take more than one 12.5 mg tablet every 24 hours.
If you accidentally take too many tablets, or if someone else or a child takes this medicine, talk to a doctor or pharmacist immediately.
Try to take Almogran as you have been prescribed. Do not take a double dose to make up for a forgotten tablet.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects ( may affect up to 1 in 10 people)
Uncommon side effects ( may affect up to 1 in 100 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Frequency unknown (frequency cannot be estimated from the available data)
During treatment with Almogran, tell your doctor straight away:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see below):
Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after “EXP”. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is almotriptan 12.5 mg (as almotriptan D,L-hydrogen malate).
The other ingredients are:
Tablet core: Mannitol (E-421), microcrystalline cellulose, povidone, sodium starch glycolate, sodium stearyl fumarate
Coating material: Hypromellose, titanium dioxide (E-171), Macrogol 400, carnauba wax
Almogran is available as a white, circular, biconvex film-coated tablet with an “A” engraved on one side.
Almogran is available in blister packs containing 2, 3, 4, 6, 7, 9, 12, 14 or 18 tablets. Not all pack sizes may be marketed.
Marketing Authorisation Holder
This medicinal product is authorised in the Member States of the EEA under the following names:
Belgium Almogran 12.5 mg filmomhulde tabletten
Denmark Almogran 12.5 mg filmovertrukne tabletter
Germany Almogran 12.5 mg Filmtablette
Greece Almogran 12.5 mg Επικαλυμμένα με λεπτό υμένιο δισκία
Finland Almogran 12.5 mg tabletti, kalvopäällysteinen
France Almogran 12.5 mg comprimé pelliculé
Iceland Almogran 12.5 mg filmuhúðaðar töflur
Ireland Almogran 12.5 mg Film-coated tablet
Italy Almogran 12.5 mg compresse rivestite con film
Luxembourg Almogran 12.5 mg comprimés pelliculés
Netherlands Almogran 12.5 mg omhulde tablet
Norway Almogran 12.5 mg filmdrasjert tablett
Portugal Almogran 12.5 mg comprimidos revestidos por película
Sweden Almogran 12.5 mg filmdragerad tablett
Spain Almogran 12.5 mg comprimidos recubiertos con película
United Kingdom Almogran 12.5 mg Film-coated tablet